E-DRUG Archives (by date)

• Thread Index

January 31, 2000
• [e-drug] Prescribing Service website
  • From: Lynn Weekes <nps@zip.com.au>
January 30, 2000
• [e-drug] Dr. Thomas Novotny's response regarding WHA Executive Board meeting
  • From: "Dr. Thomas Novotny" <TNovotny@OSOPHS.DHHS.GOV>
• [e-drug] EU and Health Registration Data
  • From: "Greg Perry" <EGA2@csi.com>
January 28, 2000
• [e-drug] Urgent Search for a Spanish Speaking Pharmacist
  • From: Gottfried Huss <Gottfried.Huss@gtz.de>
• [e-drug] 105th EB adopts resolution on HIV/AIDS
  • From: Elizabeth Hayes <HayesWaller@compuserve.com>
• [e-drug] Open letter to the USTR
  • From: MSF-Drugs Bangkok <msfdrugs@asianet.co.th>
• [e-drug] TACD on Pharma Registration Data Exclusivity (cont'd)
  • From: James Love <love@cptech.org>
• [e-drug] Drug information website
  • From: Paul Spivey <Paul_Spivey@compuserve.com>
• [e-drug] TACD on Pharma Registration Data Exclusivity (cont'd)
  • From: Greg Perry <gperry@egagenerics.com>
• [e-drug] National Drug List Launched in Malaysia
  • From: Dzulkifli Abdul Razak <dzul@prn.usm.my>
January 27, 2000
• [e-drug] USTR letter to Thailand
  • From: James Love <jamie@genoa.essential.org>
January 26, 2000
• [e-drug] Consumer International statement to WHA Executive Board
  • From: HAI <hai_in_geneva@yahoo.com>
• [e-drug] USA seeks to remove IPR section from AIDS resolution at WHO
  • From: James Love <love@cptech.org>
• [e-drug] E-DRUG: U.S. FDA UPDATES WARNINGS FOR HEARTBURN DRUG
  • From: srahmad@essential.org
• [no subject]
  • From: "Syed Ahmad 301-827-3162 FAX 301-827-5190" <AHMADS@cder.fda.gov>
• [e-drug] Beta carotene restrictions (cont'd)
  • From: Sinikka Sihvo <sinikkas@stakes.fi>
January 25, 2000
• [e-drug] Community Pharmacies Burundi (cont'd)
  • From: Scott Hillstrom <scott.hillstrom@analyticorp.co.nz>
• [e-drug] Promoting Rational Drug Use Course Nigeria (cont'd)
  • From: Martijn ten Ham <m.t.ham@minvws.nl>
• [e-drug] Community Pharmacies in Burundi (cont'd)
  • From: Shiba Karkee <dspbnmt@mos.com.np>
• [e-drug] PRDU course amendment to Trainers List
  • From: "Prof AFB Mabadaje" <biolamab@linkserve.com.ng>
• [e-drug] TACD on Pharmaceutical Registration Data Exclusivity
  • From: James Love <love@cptech.org>
• [e-drug] Health Information for Africa (Free in January 2000)
  • From: Margaret Crampton <info@nisc.co.za>
• [e-drug] Harvard Health & Internet Meeting
  • From: Bev Freeman <BevFreeman@aol.com>
January 24, 2000
• [e-drug] Promoting Rational Drug Use Course Nigeria (cont'd)
  • From: Martijn ten Ham <m.t.ham@minvws.nl>
• [e-drug] Community Pharmacies Burundi
  • From: Trish Araru <scfgit@cbinf.com>
January 22, 2000
• [e-drug] Drug donations
  • From: Scott Hillstrom <scott.hillstrom@analyticorp.co.nz>
• [e-drug] Unlicensed drug use in European countries (cont'd)
  • From: E-drug <e-drug@usa.healthnet.org>
January 21, 2000
• [e-drug] Pharmaco-economics short course - Final announcement
  • From: David Henry <mddah@mail.newcastle.edu.au>
January 20, 2000
• [e-drug] Dosing of ddI powder
  • From: MSF-Drugs Bangkok <msfdrugs@asianet.co.th>
• [e-drug] Article of interest
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] HAI letter to WHO-EB
  • From: Bas van der Heide <Bas@hai.antenna.nl>
• [e-drug] BBC-2 documentary on AIDS, drugs, SAfrica
  • From: Wilbert Bannenberg <WilbertBannenberg@compuserve.com>
• [e-drug] Generic ddI in Thailand at last (cont'd)
  • From: Toby Kasper <TobyK@gmhc.org>
• [e-drug] Increase in Global Access to Essential Drugs Sought
  • From: E-drug <e-drug@usa.healthnet.org>
• [e-drug] INRUD News now available on the Web
  • From: David Lee <inrud@msh.org>
January 19, 2000
• [e-drug] TACD draft position on transparency and economic data
  • From: James Love <love@cptech.org>
• [e-drug] TACD on early working of pharmacuetical patents
  • From: James Love <love@cptech.org>
January 18, 2000
• [e-drug] Table of contents Prescrire International, February 2000
  • From: Prescrire <international@prescrire.org>
January 17, 2000
• [e-drug] TB Drug Suppliers with FDA approval (cont'd)
  • From: Budiono Santoso <SANTOSOB@who.org.ph>
• [e-drug] Generic ddI in Thailand at last
  • From: MSF-Drugs Bangkok <msfdrugs@asianet.co.th>
• [e-drug] Standard Treatment Guidelines (cont'd)
  • From: CI-Pilar Cirugeda Campa <pcc@cruzroja.es>
• [e-drug] Indicators for community pharmacies (cont'd)
  • From: David Nelson <dnelson@ECNET.ec>
• [e-drug] TB Drug Suppliers with FDA approval (cont'd)
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] Community pharmacy indicators (cont'd)
  • From: Budiono Santoso <SANTOSOB@who.org.ph>
• [e-drug] Beta carotene restrictions (cont'd)
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Standard Treatment Guidelines
  • From: Andreas Wulf <medico.Wulf@t-online.de>
• [e-drug] Community pharmacy indicators (cont'd)
  • From: Murray Bailey <bailey_m@bigpond.com>
• [e-drug] TB Drug Suppliers with FDA approval (cont'd)
  • From: Mary Ellen Kitler <kitlerm@who.ch>
• [e-drug] Promoting Rational Drug Use Course Nigeria Jul 2000
  • From: Biola Mabadeje <biolamab@linkserve.com.ng>
• [e-drug] Projected World Pharmaceutical Market 2002
  • From: James Love <love@cptech.org>
• [e-drug] TACD statement on Access to Medicines in Developing Countries
  • From: James Love <love@cptech.org>
January 16, 2000
• [e-drug] TB Drug Suppliers with FDA approval (cont'd)
  • From: Budiono Santoso <santosob@who.org.ph>
• [e-drug] Indicators for community pharmacies? (cont'd)
  • From: Libby Roughead <Libby.Roughead@unisa.edu.au>
January 15, 2000
• [e-drug] 11th WHO Model List of Essential Drugs (cont'd)
  • From: Leo Offerhaus <lo@EURONET.NL>
• [e-drug] 11th Model List of Essential Drugs (cont'd)
  • From: Nadine Gasman <gasmanna@netmex.com>
• [e-drug] 11th WHO Model List of Essential Drugs (cont'd)
  • From: Khalil Elouardighi <gerrold@wanadoo.fr>
• [e-drug] Indicators for community pharmacies? (cont'd)
  • From: John Urquhart <urquhart@ix.netcom.com>
• [e-drug] 11th Model List of Essential Drugs (cont'd)
  • From: James Love <love@cptech.org>
January 14, 2000
• [e-drug] Indicators for community pharmacies? (cont'd)
  • From: Doug Hepler <hepler@cop.ufl.edu>
• [e-drug] 11th Model List of Essential Drugs (cont'd)
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] fraudulent skin treatments in UK
  • From: e-drug@usa.healthnet.org
• [e-drug] WHO-GLP Workshop in South Africa
  • From: Andrew Walubo <waluboa@frm.uovs.ac.za>
• [e-drug] BMJ: Generic prescribing: time to regulate the market?
  • From: e-drug@usa.healthnet.org
• [e-drug] Le Monde diplomatique: Apartheid of Pharmacology
  • From: Robert Weissman <rob@essential.org>
• [e-drug] Text from Doctors without Borders
  • From: Gabriel Mwaluko <gmwaluko@twiga.com>
• [e-drug] 11th Model List of Essential Drugs (cont'd)
  • From: Pierre Chirac <pierchir@club-internet.fr>
• [e-drug] Indicators for community pharmacies?
  • From: Ole Frank Nielsen <olefrank@nielsen-consult.dk>
• [e-drug] Africa urges wealthy countries to make AIDS drugs available,
  • From: e-drug@usa.healthnet.org
January 13, 2000
• [e-drug] 11th Model List of Essential Drugs (cont'd)
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] Beta carotene restrictions
  • From: Sinikka Sihvo <sinikkas@stakes.fi>
• [e-drug] 11th Model List of Essential Drugs (cont'd)
  • From: Pierre Chirac <pierchir@club-internet.fr>
January 12, 2000
• [e-drug] Looking for spanish speaking pharmacist
  • From: Daniel Vandenbergh <dvandenbergh@aedes.be>
• [e-drug] MSF Demands US Support to Make Affordable ddI
  • From: Daniel Berman <Daniel_Berman@geneva.msf.org>
• [e-drug] accesss to HIV-related drugs in developing countries
  • From: Anita Hardon <hardon@pscw.uva.nl>
• [e-drug] Looking for someone...
  • From: NIELSEN CONSULT <olefrank@nielsen-consult.dk>
• [e-drug] Nigerian INRUD course postponed
  • From: Wilbert Bannenberg <WilbertBannenberg@compuserve.com>
• [e-drug] PhRMA's Dec 3, 1999 NTE submission
  • From: James Love <love@cptech.org>
• [e-drug] Drug information
  • From: George Kibumba <did.jms@imul.com>
• [e-drug] generic antiretroviral donations?
  • From: "Carter, Denise" <DCarter@map.org>
January 11, 2000
• [e-drug] Drug Use in Pakistan and other resources (cont'd)
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] Price information of reference texts (cont'd)
  • From: Nadine Kamal <nadine@upmrc.org>
• [e-drug] HAI comments on draft WHO Guidelines on Interaction with Commercial Enterprises
  • From: Bas van der Heide <Bas@hai.antenna.nl>
• [e-drug] AIDS Treatment E-mail Lists
  • From: "Dr Graham Neilsen" <gneilsen@iafrica.com>
• [e-drug] Al Gore's in the UN Security Council on AIDS drugs
  • From: Thiru Balasubramaniam <thiru@cptech.org>
January 10, 2000
• [no subject]
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] HAI comments on draft WHO Guidelines on Interaction with Commercial Enterprises
  • From: Hilbrand Haak <HaakH@compuserve.com>
January 09, 2000
• [e-drug] Appearance of E-drug messages
  • From: Hilbrand Haak <HaakH@compuserve.com>
• [e-drug] Looking for Advice
  • From: Hilbrand Haak <HaakH@compuserve.com>
January 08, 2000
• [e-drug] (no subject)
  • From: Wilbert Bannenberg <emans@mweb.co.za>
• [e-drug] To: E-drug <e-drug@usa.healthnet.org>
  • From: Hilbrand Haak <HaakH@compuserve.com>
• [e-drug] To: E-drug <e-drug@usa.healthnet.org>
  • From: Hilbrand Haak <HaakH@compuserve.com>
• [e-drug] [Pharm-policy] Today's WP editorial
  • From: Wilbert Bannenberg <73377.3055@compuserve.com>
• [e-drug] [Pharm-policy] Rep. Berry's web page on pharmacuetical drugs
  • From: Wilbert Bannenberg <73377.3055@compuserve.com>
January 07, 2000
• [e-drug] To: E-drug <e-drug@usa.healthnet.org>
  • From: Hilbrand Haak <HaakH@compuserve.com>
January 04, 2000
• [e-drug] To: E-drug <e-drug@usa.healthnet.org>
  • From: Hilbrand Haak <HaakH@compuserve.com>
• [e-drug] To: E-drug <e-drug@usa.healthnet.org>
  • From: Hilbrand Haak <HaakH@compuserve.com>
• [e-drug] To: E-drug <e-drug@usa.healthnet.org>
  • From: Hilbrand Haak <HaakH@compuserve.com>